Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Seyfried TN, Mukherjee P.

J Oncol. 2010;2010:961243. doi: 10.1155/2010/961243. Epub 2010 Jun 20.

2.

Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma.

Abate LE, Mukherjee P, Seyfried TN.

J Neurochem. 2006 Sep;98(6):1973-84. Epub 2006 Aug 14.

3.

Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a.

Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN.

J Lipid Res. 2008 May;49(5):929-38. doi: 10.1194/jlr.R800006-JLR200. Epub 2008 Feb 20.

4.

Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.

Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.

Glycobiology. 2009 Mar;19(3):229-39. doi: 10.1093/glycob/cwn114. Epub 2008 Oct 30.

PMID:
18974200
5.

Ganglioside distribution in murine neural tumors.

Seyfried TN, el-Abbadi M, Roy ML.

Mol Chem Neuropathol. 1992 Oct;17(2):147-67.

PMID:
1418222
6.
7.

Ganglioside composition and its relation to clinical data in brain tumors.

Shinoura N, Dohi T, Kondo T, Yoshioka M, Takakura K, Oshima M.

Neurosurgery. 1992 Sep;31(3):541-9.

PMID:
1407435
8.

Angiogenic and angiostatic microenvironment in tumors--role of gangliosides.

Alessandri G, Cornaglia-Ferraris P, Gullino PM.

Acta Oncol. 1997;36(4):383-7.

PMID:
9247098
9.

Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors.

Mukherjee P, Abate LE, Seyfried TN.

Clin Cancer Res. 2004 Aug 15;10(16):5622-9.

10.

Cancer vaccines: an update with special focus on ganglioside antigens.

Bitton RJ, Guthmann MD, Gabri MR, Carnero AJ, Alonso DF, Fainboim L, Gomez DE.

Oncol Rep. 2002 Mar-Apr;9(2):267-76. Review.

PMID:
11836591
11.

Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.

Hayashi N, Chiba H, Kuronuma K, Go S, Hasegawa Y, Takahashi M, Gasa S, Watanabe A, Hasegawa T, Kuroki Y, Inokuchi J, Takahashi H.

Cancer Sci. 2013 Jan;104(1):43-7. doi: 10.1111/cas.12027. Epub 2012 Oct 30.

14.
15.

[Lipid composition of human malignant brain tumors].

Nakamura O, Ishihara E, Iwamori M, Nagai T, Matsutani M, Nomura K, Takakura K.

No To Shinkei. 1987 Mar;39(3):221-6. Japanese.

PMID:
3034315
16.

Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio.

Ziche M, Morbidelli L, Alessandri G, Gullino PM.

Lab Invest. 1992 Dec;67(6):711-5.

PMID:
1281244
18.

Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides.

Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG.

J Biol Chem. 2002 Mar 22;277(12):10108-13. Epub 2002 Jan 16.

19.

Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

Yu RK, Macala LJ, Taki T, Weinfield HM, Yu FS.

J Neurochem. 1988 Jun;50(6):1825-9.

PMID:
3131485
20.

Ganglioside GM3:GD3 ratio as an index for the management of melanoma.

Ravindranath MH, Tsuchida T, Morton DL, Irie RF.

Cancer. 1991 Jun 15;67(12):3029-35.

Supplemental Content

Support Center